The UK MHRA has validated Bavarian Nordics’ marketing authorisation application for its single-dose chikungunya vaccine.

The more mosquitoes there are, the longer they stay active, and which species they bite all matters. With Florida under ...

In the years to come, Bavarian Nordic foresees that more commercially minded-business taking the lead over the sort of ...

The following is a summary of “Transcriptomic insights into early mechanisms underlying post-chikungunya chronic inflammatory ...

The European Commission (EC) has authorised the marketing of Bavarian Nordic's Vimkunya - the first chikungunya vaccine ...

Five people have been hospitalized with cardiac and neurological symptoms after getting the chikungunya vaccine.

Bavarian Nordic, a Danish biotechnology company specializing in vaccine development, was on 28 February 2025 granted ...

The European Commission on Friday authorized a vaccine against the chikungunya virus - a mosquito-borne disease - for adults and young people aged 12 and over. "The commission is determined to use all ...

If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 – ...

(CNN) — The US Centers for Disease Control and Prevention is currently investigating five hospitalizations that occurred in people who had recently received a vaccine that prevents disease caused by ...

all65 and older, were hospitalized for cardiac or neurologic events following vaccination with IXCHIQ, the only chikungunya vaccine currently licensed in the United States.

CNN has reached out to the CDC for comment. Chikungunya virus is typically spread to people through the bite of an infected mosquito. Most adults don’t receive the vaccine; it is sometimes ...